Marketing & Sales · Brand & Product Management

Pharmaceutical Launch Strategy: Pipeline to Market

Simulation where participants act as Commercial Launch Director for CARDIVEX (empavatin), allocating an $18M budget across six strategic levers over five rounds to take a novel Type 2 Diabetes drug from regulatory approval to commercial profitability against branded competitors and impending generic entry.

5 rounds Executive English, Español
All simulations Get started
Preview

Who it is for

An advanced simulation for participants used to working with the main frameworks and trade-offs of the subject, designed for executive education and experienced professionals.

How a session runs

  1. The instructor creates a session from the Eureka dashboard and invites the participants.
  2. Participants play 5 rounds. In each one they submit their decisions and the simulation calculates the results.
  3. The simulation can be run in English, Español.
  4. The instructor follows each participant's progress and results from the dashboard, and uses the class results for the debrief.

Decisions participants make

The decisions participants make during the simulation:

  • A — Market Access and HEOR
  • B — Medical Affairs / KOL
  • C — Salesforce
  • D — Brand and Promotion
  • E — Patient Support Programs
  • F — Lifecycle Management

What participants track

What participants follow on screen as the rounds go by:

  • Budget Allocation (units of $250,000)

Subjects covered

Designed for courses in Brand & Product Management.

  • Product Management & New Product Development
  • Go-To-Market Strategy
  • Healthcare Marketing

See all Marketing & Sales simulations →

Ready to use Pharmaceutical Launch Strategy: Pipeline to Market with your students?

Contact us and we'll set you up with a free trial session.

Contact us